2022 Vol.40, N°5 - Table of contents
May 2022
Full Papers
CER14477
2022,40,5
Pg. 0867-0871
Free to view
Therapeutic responses and predictors of low-dose interleukin-2 in systemic lupus erythematosus
M. Miao, Y. Li, D. Xu, R. Zhang, J. He, X. Sun, Z. Li
DOI: https://doi.org/10.55563/clinexprheumatol/1o6pn1
M. Miao, Y. Li, D. Xu, R. Zhang, J. He, X. Sun, Z. Li
DOI: https://doi.org/10.55563/clinexprheumatol/1o6pn1
CER14388
2022,40,5
Pg. 0872-0881
Free to view
Rate and predictors of chronic organ damage accrual in active lupus nephritis: a single centre experience over 18 years of observation
G. Frontini, F. Tamborini, G. Porata, A. Regalia, V. Binda, G. Moroni
DOI: https://doi.org/10.55563/clinexprheumatol/ig0lu0
G. Frontini, F. Tamborini, G. Porata, A. Regalia, V. Binda, G. Moroni
DOI: https://doi.org/10.55563/clinexprheumatol/ig0lu0
CER14339
2022,40,5
Pg. 0882-0889
User experience with a voice-enabled smartphone app to collect patient-reported outcomes in rheumatoid arthritis
M.T. Murray, S.P. Penney, A. Landman, J. Elias, B. Mullen, H. Sipe, B. Hartog, E. Richard, C. Xu, D.H. Solomon
DOI: https://doi.org/10.55563/clinexprheumatol/xsdfl2
M.T. Murray, S.P. Penney, A. Landman, J. Elias, B. Mullen, H. Sipe, B. Hartog, E. Richard, C. Xu, D.H. Solomon
DOI: https://doi.org/10.55563/clinexprheumatol/xsdfl2
CER14434
2022,40,5
Pg. 0890-0896
Free to view
Hydroxychloroquine cardiotoxicity: a case-control study comparing patients with COVID-19 and patients with systemic lupus erythematosus
S. Mancuso, F.R. Spinelli, L. Agati, M.R. Ciardi, C. Garufi, F. Natalucci, E. Molteni, S. Truglia, V. Riccieri, R. Priori, C.M. Mastroianni, F. Conti
DOI: https://doi.org/10.55563/clinexprheumatol/7ullgb
S. Mancuso, F.R. Spinelli, L. Agati, M.R. Ciardi, C. Garufi, F. Natalucci, E. Molteni, S. Truglia, V. Riccieri, R. Priori, C.M. Mastroianni, F. Conti
DOI: https://doi.org/10.55563/clinexprheumatol/7ullgb
CER14510
2022,40,5
Pg. 0897-0903
Soluble ST2 is increased in systemic lupus erythematous and is a potential marker of lupus nephritis
A. Moreau, C. Nicaise, A. Awada, M.S. Soyfoo
DOI: https://doi.org/10.55563/clinexprheumatol/eg3a2k
A. Moreau, C. Nicaise, A. Awada, M.S. Soyfoo
DOI: https://doi.org/10.55563/clinexprheumatol/eg3a2k
CER14303
2022,40,5
Pg. 0904-0912
Free to view
Subclinical enthesopathy of the midfoot: could it be a peculiar feature in early psoriatic arthritis?
M. Lorenzin, A. Ortolan, G. Cherobin, P. Zucchetta, G. Cozzi, R. Stramare, A. Doria, R. Ramonda
DOI: https://doi.org/10.55563/clinexprheumatol/umzdgd
M. Lorenzin, A. Ortolan, G. Cherobin, P. Zucchetta, G. Cozzi, R. Stramare, A. Doria, R. Ramonda
DOI: https://doi.org/10.55563/clinexprheumatol/umzdgd
CER14502
2022,40,5
Pg. 0913-0920
Malignancies in spondyloarthritis with and without concomitant psoriasis, and the effect of disease modifying anti-rheumatic drugs
H.Y. Chung, S.C.W. Chan, E.T.F. Chui, T. Yau, C.S. Lau
DOI: https://doi.org/10.55563/clinexprheumatol/o3rgv1
H.Y. Chung, S.C.W. Chan, E.T.F. Chui, T. Yau, C.S. Lau
DOI: https://doi.org/10.55563/clinexprheumatol/o3rgv1
CER14463
2022,40,5
Pg. 0921-0927
The role of musculoskeletal ultrasound in predicting the response to JAK inhibitors: results from a monocentric cohort
F. Ceccarelli, F.R. Spinelli, C. Garufi, S. Mancuso, C. Alessandri, M. Di Franco, V. Orefice, V.A. Pacucci, C. Pirone, R. Priori, V. Riccieri, A. Sili Scavalli, R. Scrivo, S. Truglia, F. Conti
DOI: https://doi.org/10.55563/clinexprheumatol/totvyv
F. Ceccarelli, F.R. Spinelli, C. Garufi, S. Mancuso, C. Alessandri, M. Di Franco, V. Orefice, V.A. Pacucci, C. Pirone, R. Priori, V. Riccieri, A. Sili Scavalli, R. Scrivo, S. Truglia, F. Conti
DOI: https://doi.org/10.55563/clinexprheumatol/totvyv
CER14310
2022,40,5
Pg. 0928-0935
Free to view
Adherence to and patient’s knowledge of self-management of subcutaneous biologic therapy in chronic inflammatory rheumatic diseases: results of a multicentre cross-sectional study
V. Gaud-Listrat, C. Lopez-Medina, C. Hudry, M. Nguyen, A. Lebrun-Foisnet, A. Sacchi, S. Labatide Alanore, E. Dernis, P. Le Devic, J. Fechtenbaum, C. Richard-Miceli, P. Le Goux, S. Dadoun, A. Moltό, A. Blanchais-Behr, S. Neveu, M. Benhamou, B. Giraud, C. Roux, M. Dougados
on behalf of the RHEVER network (Hospital and City in Rheumatology Network)
DOI: https://doi.org/10.55563/clinexprheumatol/slk3yz
V. Gaud-Listrat, C. Lopez-Medina, C. Hudry, M. Nguyen, A. Lebrun-Foisnet, A. Sacchi, S. Labatide Alanore, E. Dernis, P. Le Devic, J. Fechtenbaum, C. Richard-Miceli, P. Le Goux, S. Dadoun, A. Moltό, A. Blanchais-Behr, S. Neveu, M. Benhamou, B. Giraud, C. Roux, M. Dougados
on behalf of the RHEVER network (Hospital and City in Rheumatology Network)
DOI: https://doi.org/10.55563/clinexprheumatol/slk3yz
CER14362
2022,40,5
Pg. 0936-0944
Free to view
The importance of specific citrullinated clusterin and vimentin found in a multi-coloured bead-based citrulline-peptide array system in rheumatoid arthritis
Y. Yoshizawa, T. Nakao, K. Tsuritani, T. Yamada, N. Watanabe, A. Chiba, W.H. Robinson, S. Miyake
DOI: https://doi.org/10.55563/clinexprheumatol/ucnzun
Y. Yoshizawa, T. Nakao, K. Tsuritani, T. Yamada, N. Watanabe, A. Chiba, W.H. Robinson, S. Miyake
DOI: https://doi.org/10.55563/clinexprheumatol/ucnzun
CER14454
2022,40,5
Pg. 0945-0951
Free to view
Plasma micro-RNA-22 is associated with disease activity in well-established rheumatoid arthritis
M. Cieśla, B. Kolarz, M. Majdan, D. Darmochwał-Kolarz
DOI: https://doi.org/10.55563/clinexprheumatol/zdhkrp
M. Cieśla, B. Kolarz, M. Majdan, D. Darmochwał-Kolarz
DOI: https://doi.org/10.55563/clinexprheumatol/zdhkrp
CER14515
2022,40,5
Pg. 0952-0959
Secukinumab provides sustained improvement in nail psoriasis, signs and symptoms of psoriatic arthritis and low rate of radiographic progression in patients with concomitant nail involvement: 2-year results from the Phase III FUTURE 5 study
P. Nash, P.J. Mease, B. Kirkham, A. Singhal, E. Quebe-Fehling, L. Pricop, C. Gaillez
DOI: https://doi.org/10.55563/clinexprheumatol/3nuz51
P. Nash, P.J. Mease, B. Kirkham, A. Singhal, E. Quebe-Fehling, L. Pricop, C. Gaillez
DOI: https://doi.org/10.55563/clinexprheumatol/3nuz51
CER14436
2022,40,5
Pg. 0960-0966
Proliferative synovitis, an ultrasound pattern associated with ACPA-positive patients and erosive disease in rheumatoid arthritis
J. Ramírez, A.B. Azuaga-Piñango, B. Frade-Sosa, R. Gumucio-Sanguino, K. Cajiao-Sánchez, A.M. Cuervo, R. Celis, J.A. Narváez, V. Ruiz-Esquide, R. Castellanos-Moreira, A. Ponce, J.A. Gómez-Puerta, J.L. Pablos, R. Sanmartí, J.D. Cañete
DOI: https://doi.org/10.55563/clinexprheumatol/so5skx
J. Ramírez, A.B. Azuaga-Piñango, B. Frade-Sosa, R. Gumucio-Sanguino, K. Cajiao-Sánchez, A.M. Cuervo, R. Celis, J.A. Narváez, V. Ruiz-Esquide, R. Castellanos-Moreira, A. Ponce, J.A. Gómez-Puerta, J.L. Pablos, R. Sanmartí, J.D. Cañete
DOI: https://doi.org/10.55563/clinexprheumatol/so5skx
CER14425
2022,40,5
Pg. 0967-0974
Free to view
Effects of ankylosing spondylitis and non-radiographic axial spondyloarthropathy on female sexual functions
M. Gözüküçük, E. Türkyilmaz, O. Küçükşahin, Ş. Erten, Y. Üstün, A.F. Yavuz
DOI: https://doi.org/10.55563/clinexprheumatol/raqpga
M. Gözüküçük, E. Türkyilmaz, O. Küçükşahin, Ş. Erten, Y. Üstün, A.F. Yavuz
DOI: https://doi.org/10.55563/clinexprheumatol/raqpga
CER14493
2022,40,5
Pg. 0975-0979
Local adaptation of recommendation-based materials for shared decision-making and management of comorbidity in rheumatoid arthritis
J.M. Álvaro Gracia, C. Barbazán, J.F. García Llorente, S. Muñóz-Fernández, A. Gómez Centeno, A. Urruticoechea-Arana, M.Á. Caracuel, E. Loza, J. Calvo-Alén
DOI: https://doi.org/10.55563/clinexprheumatol/kypaiv
J.M. Álvaro Gracia, C. Barbazán, J.F. García Llorente, S. Muñóz-Fernández, A. Gómez Centeno, A. Urruticoechea-Arana, M.Á. Caracuel, E. Loza, J. Calvo-Alén
DOI: https://doi.org/10.55563/clinexprheumatol/kypaiv
CER14543
2022,40,5
Pg. 0980-0987
Free to view
Central sensitisation features are associated with neuropathic pain-like symptoms in patients with longstanding rheumatoid arthritis: a cross-sectional study using the central sensitisation inventory
M. Saitou, K. Noda, T. Matsushita, T. Ukichi, D. Kurosaka
DOI: https://doi.org/10.55563/clinexprheumatol/msy022
M. Saitou, K. Noda, T. Matsushita, T. Ukichi, D. Kurosaka
DOI: https://doi.org/10.55563/clinexprheumatol/msy022
CER14621
2022,40,5
Pg. 0988-0992
Free to view
Role of adiponectin in non-diabetic patients with rheumatoid arthritis undergoing anti-IL-6 therapy
V. Pulito-Cueto, S. Remuzgo-Martínez, F. Genre, J. Calvo-Alén, E. Aurrecoechea, I. Llorente, A. Triguero-Martinez, R. Blanco, J. Llorca, E. Ruiz-Lucea, N. Rivera-García, O. Gualillo, R. López-Mejías, S. Castañeda, M.A. González-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/p8nx80
V. Pulito-Cueto, S. Remuzgo-Martínez, F. Genre, J. Calvo-Alén, E. Aurrecoechea, I. Llorente, A. Triguero-Martinez, R. Blanco, J. Llorca, E. Ruiz-Lucea, N. Rivera-García, O. Gualillo, R. López-Mejías, S. Castañeda, M.A. González-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/p8nx80
CER14509
2022,40,5
Pg. 0993-0998
Flexion contracture is associated with knee joint degeneration on magnetic resonance imaging: data from the Osteoarthritis Initiative
T.M. Campbell, G. Trudel, P.G. Conaghan, K. Reilly, R.J. Feibel, D. Mcgonagle
DOI: https://doi.org/10.55563/clinexprheumatol/u8itzf
T.M. Campbell, G. Trudel, P.G. Conaghan, K. Reilly, R.J. Feibel, D. Mcgonagle
DOI: https://doi.org/10.55563/clinexprheumatol/u8itzf
CER14607
2022,40,5
Pg. 0999-1005
Free to view
Prognostic signature of interferon-γ and interleurkin-17A in early rheumatoid arthritis
K. Lee, H.K. Min, S.-H. Koh, S.-H. Lee, H.-R. Kim, J.H. Ju, H.-Y. Kim
DOI: https://doi.org/10.55563/clinexprheumatol/mkbvch
K. Lee, H.K. Min, S.-H. Koh, S.-H. Lee, H.-R. Kim, J.H. Ju, H.-Y. Kim
DOI: https://doi.org/10.55563/clinexprheumatol/mkbvch
CER14215
2022,40,5
Pg. 1006-1010
Pegloticase causes prolonged improvement in multiple disease parameters in patients with chronic refractory gout who maintain low serum urate levels
R.T. Keenan, A.E. Yeo, P.E. Lipsky
DOI: https://doi.org/10.55563/clinexprheumatol/3m095f
R.T. Keenan, A.E. Yeo, P.E. Lipsky
DOI: https://doi.org/10.55563/clinexprheumatol/3m095f
CER14672
2022,40,5
Pg. 1011-1018
Free to view
Untargeted lipidomics reveals specific lipid abnormalities in systemic lupus erythematosus
Y. Wang, F. Guo, Y. Guo, Y. Lu, W. Ji, L. Lin, W. Chen, T. Xu, D. Kong, Q. Shen, Y. Zhu, P. Liu, J. Su, L. Wang, Y. Li, P. Gao, J. Shan, S. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/ye2ua5
Y. Wang, F. Guo, Y. Guo, Y. Lu, W. Ji, L. Lin, W. Chen, T. Xu, D. Kong, Q. Shen, Y. Zhu, P. Liu, J. Su, L. Wang, Y. Li, P. Gao, J. Shan, S. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/ye2ua5
CER14458
2022,40,5
Pg. 1019-1024
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study
S. Perniola, R. Bizzoca, M. Fornaro, S. Alivernini, E. Gremese, F. Iannone
DOI: https://doi.org/10.55563/clinexprheumatol/akl60y
S. Perniola, R. Bizzoca, M. Fornaro, S. Alivernini, E. Gremese, F. Iannone
DOI: https://doi.org/10.55563/clinexprheumatol/akl60y
CER14356
2022,40,5
Pg. 1025-1033
Comparison of the efficacy and safety of LBAL, a candidate adalimumab biosimilar, and adalimumab reference product in patients with active rheumatoid arthritis inadequately responding to methotrexate: a 52-week phase III randomised study
H. Matsuno, Y.M. Kang, M. Okada, S.-I. Lee, S.-H. Park, D.H. Sheen, M. Sato, A. Hagino, J. Lee, S. Shin, Y.W. Song
DOI: https://doi.org/10.55563/clinexprheumatol/cyudn8
H. Matsuno, Y.M. Kang, M. Okada, S.-I. Lee, S.-H. Park, D.H. Sheen, M. Sato, A. Hagino, J. Lee, S. Shin, Y.W. Song
DOI: https://doi.org/10.55563/clinexprheumatol/cyudn8
Brief Paper
CER15118
2022,40,5
Pg. 1034-1037
Symptomatic and structural benefit of cathepsin K inhibition by MIV-711 in a subgroup with unilateral pain: post-hoc analysis of a randomised phase 2a clinical trial
A.R. Bihlet, I. Byrjalsen, J.R. Andersen, F. Öberg, C. Herder, M.A. Bowes, P.G. Conaghan
DOI: https://doi.org/10.55563/clinexprheumatol/1kvgte
A.R. Bihlet, I. Byrjalsen, J.R. Andersen, F. Öberg, C. Herder, M.A. Bowes, P.G. Conaghan
DOI: https://doi.org/10.55563/clinexprheumatol/1kvgte
Review
CER14545
2022,40,5
Pg. 1038-1044
Free to view
Role of eosinophilia in IgG4-related disease
B. Ming, J. Zhong, L. Dong
DOI: https://doi.org/10.55563/clinexprheumatol/l7se2n
B. Ming, J. Zhong, L. Dong
DOI: https://doi.org/10.55563/clinexprheumatol/l7se2n
Paediatric Rheumatology
CER15193
2022,40,5
Pg. 1045-1051
Clinical features, treatment patterns and short-term outcomes of children with inflammatory bowel disease evaluated in rheumatology clinic
A.O. Bilgic Dagci, J.C. Chang, T.G. Brandon, H.E. Goheer, P.F. Weiss
DOI: https://doi.org/10.55563/clinexprheumatol/2xhxrk
A.O. Bilgic Dagci, J.C. Chang, T.G. Brandon, H.E. Goheer, P.F. Weiss
DOI: https://doi.org/10.55563/clinexprheumatol/2xhxrk
Letters to the Editor
CER15003
2022,40,5
Pg. 1052-1053
Free to view
Multifocal fibrosclerosis in a patient with HIV infection treated with rituximab
S. Scriffignano, D. Mauro, M. Raimondi, F. Ciccia, R. Tirri
DOI: https://doi.org/10.55563/clinexprheumatol/7inedr
S. Scriffignano, D. Mauro, M. Raimondi, F. Ciccia, R. Tirri
DOI: https://doi.org/10.55563/clinexprheumatol/7inedr
CER15192
2022,40,5
Pg. 1054-1055
Free to view
Catastrophic antiphospholipid syndrome triggered by mRNA COVID-19 vaccine
V. Moreno-Torres, Á. Gutiérrez, M. Valdenebro, A. Ortega, M.-J. Cítores, E. Montero
DOI: https://doi.org/10.55563/clinexprheumatol/s3sbgu
V. Moreno-Torres, Á. Gutiérrez, M. Valdenebro, A. Ortega, M.-J. Cítores, E. Montero
DOI: https://doi.org/10.55563/clinexprheumatol/s3sbgu
CER14906
2022,40,5
Pg. 1056-1057
Free to view
Complex regional pain syndrome of the foot in a girl with post-SARS-CoV-2 chilblains
F. Peri, S. Della Paolera, E. Conversano, F.M. Murru, A. Tommasini, A. Taddio
DOI: https://doi.org/10.55563/clinexprheumatol/xfu3g0
F. Peri, S. Della Paolera, E. Conversano, F.M. Murru, A. Tommasini, A. Taddio
DOI: https://doi.org/10.55563/clinexprheumatol/xfu3g0
CER14836
2022,40,5
Pg. 1058
Free to view
Intra-articular osteoid osteoma mimicking juvenile psoriatic dactylitis
L. Breda, G. Sassano, S. La Bella, C. Gentile, L. Sansone, F. Chiarelli
DOI: https://doi.org/10.55563/clinexprheumatol/a55rk0
L. Breda, G. Sassano, S. La Bella, C. Gentile, L. Sansone, F. Chiarelli
DOI: https://doi.org/10.55563/clinexprheumatol/a55rk0
CER14965
2022,40,5
Pg. 1059
Free to view
CER15130
2022,40,5
Pg. 1060
Free to view
Macrophage activation syndrome after BNT162b2 mRNA vaccination successfully treated with corticosteroids
N. Ashizawa, T. Takazono, M. Umeda, K. Yamamoto, A. Kawakami, H. Mukae
DOI: https://doi.org/10.55563/clinexprheumatol/a9hrmo
N. Ashizawa, T. Takazono, M. Umeda, K. Yamamoto, A. Kawakami, H. Mukae
DOI: https://doi.org/10.55563/clinexprheumatol/a9hrmo
CER14905
2022,40,5
Pg. 1061
Free to view
COVID-19 clinical spectrum in psoriatic arthritis patients on biologics and tsDMARDs: results from a cohort at an Italian epicentre of the pandemic’s third wave
M. Tasso, E. Mostacciuolo, V. Ugoccioni, A. Del Puente, R. Peluso, R. Scarpa, L. Costa, F. Caso
DOI: https://doi.org/10.55563/clinexprheumatol/8839ak
M. Tasso, E. Mostacciuolo, V. Ugoccioni, A. Del Puente, R. Peluso, R. Scarpa, L. Costa, F. Caso
DOI: https://doi.org/10.55563/clinexprheumatol/8839ak
CER15129
2022,40,5
Pg. 1062-1063
Free to view
Exploring the role of rheumatic and musculoskeletal disease patient organisations during the COVID-19 pandemic: results from the REUMAVID study (phase 1)
M. Garrido-Cumbrera, H. Marzo-Ortega, L. Christen, J. Correa-Fernández, S. Sanz-Gómez, V. Navarro-Compán
on behalf of the REUMAVID Working Group.
DOI: https://doi.org/10.55563/clinexprheumatol/g4irgy
M. Garrido-Cumbrera, H. Marzo-Ortega, L. Christen, J. Correa-Fernández, S. Sanz-Gómez, V. Navarro-Compán
on behalf of the REUMAVID Working Group.
DOI: https://doi.org/10.55563/clinexprheumatol/g4irgy